Salivary Gland Tumors
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 (NCT05601401) | Peking Union Medical College Hospital | 2022-03-31 |
| Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms (NCT05000892) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-12-10 |
| Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms (NCT04825938) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-04-30 |
| Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas (NCT02776163) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2016-06-01 |
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors (NCT02921984) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2013-09-01 |
Track Salivary Gland Tumors automatically
Every clearance here is in the API, with alerts when new ones post.